Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Modified exosomes for targeted delivery of doxorubicin and carvedilol to mitochondria in breast cancer cells.

Scientific reports·2025

Same author

Machine learning-driven optimization of culture conditions and media components to mitigate charge heterogeneity in monoclonal antibody production: current advances and future perspectives.

mAbs·2025

Same author

Evaluation of curcumin (CUR) loaded BSA nanoparticles for <i>in-vitro</i> photodynamic therapy on MCF-7 cell line.

Drug development and industrial pharmacy·2025

Same author

Folate-functionalized Zein-PEI nanoparticles for targeted cancer therapy: Integrated experimental and molecular dynamics insights into stability, uptake, and cytotoxicity.

International journal of biological macromolecules·2025

Same author

Protein-based nanocarriers for paclitaxel (PTX) delivery in cancer treatment: A review.

International journal of biological macromolecules·2025

Same author

Damage sensing through TLR9 regulates inflammatory and antiviral responses during influenza infection.

Mucosal immunology·2025

Search research articles

Related Experiment Video

Updated: Mar 25, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Multifunctional nanoparticles for cancer immunotherapy.

Tayebeh Saleh¹, Seyed Abbas Shojaosadati²

¹a Department of Nanobiotechnology , Faculty of Biological Sciences, Tarbiat Modares University , Tehran , Iran.

Human Vaccines & Immunotherapeutics

|February 23, 2016

Summary

Multifunctional nanoparticles offer a promising approach to overcome limitations in cancer vaccines, enhancing their effectiveness by improving antigen delivery and immune response. These advanced systems target immune cells and reduce adverse effects for better cancer immunotherapy outcomes.

Keywords:

cancer vaccine delivery system immunotherapy multifunctional nanoparticle tumor microenvironment

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Related Experiment Videos

Last Updated: Mar 25, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Area of Science:

Immunology
Nanotechnology
Oncology

Background:

Cancer immunotherapy has advanced, but cancer vaccines face challenges like poor antigen immunogenicity and safety concerns.
Traditional vaccine delivery methods are limited by systemic toxicity and the complex tumor microenvironment.
Nanotechnology-based delivery systems offer novel strategies to enhance cancer vaccine efficacy.

Purpose of the Study:

To review the progress and future potential of multifunctional nanoparticles in cancer vaccine development.
To highlight how nanoparticles can overcome existing limitations in cancer vaccine therapy.
To explore nanoparticle-mediated strategies for improving cancer vaccine immunogenicity and safety.

Main Methods:

Review of recent scientific literature on nanotechnology applications in cancer vaccines.
Analysis of multifunctional nanoparticle designs for targeted delivery and immune activation.
Evaluation of nanoparticle-mediated strategies for enhancing antigen presentation and immune response.

Main Results:

Multifunctional nanoparticles enable targeted delivery of cancer vaccine antigens to immune cells.
These systems can co-deliver therapeutic agents and block immune checkpoint molecules.
Nanoparticles reduce adverse effects and amplify immune activation, improving vaccine efficacy.

Conclusions:

Multifunctional nanoparticles represent a significant advancement in cancer vaccine technology.
They offer a versatile platform to address key challenges in cancer immunotherapy.
Continued research in this area holds great promise for developing more effective cancer vaccines.